Doctronic reports that Foundayo, an oral GLP-1 for diabetes, shows promise but lacks long-term safety data beyond 68 weeks; ongoing studies are needed.

GoodRx reports that medication lockboxes enhance safety, preventing accidental ingestion and misuse, especially in homes with children or controlled substances.